EWP
ALXN

Engrave Wealth Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Engrave Wealth Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-92
Closed -$10K – 470
2020
Q2 		$10K Buy
92
+41
+80% +$4.46K 0.01% 251
2020
Q1 		$4K Sell
51
-64
-56% -$5.02K ﹤0.01% 305
2019
Q4 		$12K Buy
+115
New +$12K 0.01% 286